Results 141 to 150 of about 16,185 (163)

Predicting Response to Switching From Phosphodiesterase Type 5 Inhibitor to Riociguat in Patients With Pulmonary Arterial Hypertension: Biomarker and Responder Analysis of the RESPITE and REPLACE Studies. [PDF]

Pulm Circ
Klinger JR, Al-Hiti H, Chang SA, Chang HJ, Ghofrani HA, Grünig E, Hoeper MM, Jansa P, Ota-Arakaki J, Pulido T, Simonneau G, Vizza CD, Rahner C, Meier C, Meyer G.   +14 more
europepmc   +1 more source

[HEARTS in the Americas: targeting health system change to improve population hypertension controlHEARTS nas Américas: impulsionar mudanças no sistema de saúde para melhorar o controle da hipertensão arterial na população]. [PDF]

Rev Panam Salud Publica
Ordunez P, Campbell NRC, DiPette DJ, Jaffe MG, Rosende A, Martínez R, Gamarra A, Lombardi C, Parra N, Rodríguez L, Rodríguez Y, Brettler J.   +11 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Management of portal vein thrombosis in liver cirrhosis

Nature Reviews Gastroenterology and Hepatology, 2014
Xingshun Qi, Guohong Han, Daiming Fan
exaly  

Imaging in clinical decision-making for portal vein thrombosis

Nature Reviews Gastroenterology and Hepatology, 2014
Annalisa Berzigotti, Ángeles García-Criado, Anna Darnell   +2 more
exaly  

SYMPATHETIC TONE MODULATES PORTAL VENOUS PRESSURE IN ALCOHOLIC CIRRHOSIS

Lancet, The, 1986
Garry L Jennings
exaly  

β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial

Lancet, The, 2019
Candid Villanueva, Agustín Albillos, J Genesca   +2 more
exaly  

Portal hypertension and variceal haemorrhage

Lancet, The, 1997
Adrian J Stanley
exaly  

DNA-Packing Portal and Capsid-Associated Tegument Complexes in the Tumor Herpesvirus KSHV

Cell, 2019
Danyang Gong, Xinghong Dai, Jonathan Jih
exaly  

Adjuvant portal-vein infusion of fluorouracil and heparin in colorectal cancer: a randomised trial

Lancet, The, 1998
Donato Nitti, Desmond Curran, Roberto Labianca   +2 more
exaly